Sign In
Last checked at 
18 Apr 2024 07:00
AXIS/CO/CS/37/2024-25
April 17, 2024
Dear Sir(s),
REF.: | DISCLOSURE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 ("SEBI LISTING REGULATIONS") |
SUB.:
| UPDATE ON SUSBCRIPTION TO EQUITY SHARES OF MAX LIFE INSURANCE COMPANY LIMITED - DEAL CLOSURE |
This is with reference to our earlier disclosure letter nos. AXIS/CO/CS/253/2023-24 and AXIS/CO/CS/3/2024-25 dated August 9, 2023, and April 3, 2024, respectively, informing the exchanges about the proposed infusion of Rs. ~1,612 crore by subscribing to the equity share capital of Max Life Insurance Company Limited ("Max Life") by Axis Bank Limited ("the Bank"), and receipt of requisite regulatory approvals for the said transaction.
In this regard, we would like to inform you that the Bank on April 17, 2024, has subscribed to 14,25,79,161 fully paid-up equity shares (face value Rs. 10 each) of Max Life at a fair market value (using Discounted Cash Flow method) of Rs. 113.06 per share amounting to ~Rs. 1,612 crore.
Pursuant to the aforesaid subscription and allotment, the Bank's direct stake in Max Life has increased from 9.99% to 16.22%, and the collective stake of the Bank and its subsidiaries viz Axis Securities Limited and Axis Capital Limited has increased from 12.99% to 19.02%.
This is for your information and records.
Thanking You.
Yours faithfully,
For Axis Bank Limited
Sandeep Poddar
Company Secretary
http://www.rns-pdf.londonstockexchange.com/rns/0450L_1-2024-4-17.pdf
Follow the stocks
